US5705732A
(en)
*
|
1989-06-12 |
1998-01-06 |
Oklahoma Medical Research Foundation |
Universal donor cells
|
US5538722A
(en)
*
|
1989-06-13 |
1996-07-23 |
Stanford University |
Isolation, growth, differentiation and genetic engineering of human muscle cells
|
US5574205A
(en)
*
|
1989-07-25 |
1996-11-12 |
Cell Genesys |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
US5464764A
(en)
*
|
1989-08-22 |
1995-11-07 |
University Of Utah Research Foundation |
Positive-negative selection methods and vectors
|
US6689610B1
(en)
*
|
1989-08-22 |
2004-02-10 |
University Of Utah Research Foundation |
Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
|
US6673986B1
(en)
*
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US7041871B1
(en)
*
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5661016A
(en)
*
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5877397A
(en)
*
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5814318A
(en)
*
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5489742A
(en)
*
|
1990-10-23 |
1996-02-06 |
Board Of Regents, The University Of Texas System |
Transgenic rats and animal models of inflammatory disease
|
WO1992009688A1
(en)
*
|
1990-11-21 |
1992-06-11 |
Massachusetts Institute Of Technology |
MICE HAVING β2 MICROGLOBULIN GENE DISRUPTION
|
WO1992021763A1
(en)
*
|
1991-05-31 |
1992-12-10 |
Genentech, Inc. |
Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
|
CA2113089C
(en)
*
|
1991-07-15 |
2007-11-06 |
Peter J. Sims |
Universal donor cells
|
AU2515992A
(en)
*
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
SG47979A1
(en)
*
|
1991-11-14 |
1998-04-17 |
Charles Weissman |
Transgenic animals lacking prion proteins
|
US20020108136A1
(en)
*
|
1997-03-21 |
2002-08-08 |
Sri |
Transgenic animals produced by homologous sequence targeting
|
US6916654B1
(en)
*
|
1992-06-29 |
2005-07-12 |
Oklahoma Medical Research Foundation |
Universal donor cells
|
DE4228162C1
(de)
|
1992-08-25 |
1994-01-13 |
Rajewsky Klaus Dr |
Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern
|
JP3741447B2
(ja)
*
|
1992-10-23 |
2006-02-01 |
中外製薬株式会社 |
エンドセリン−1遺伝子の機能が欠損したマウス
|
WO1994016080A1
(en)
*
|
1993-01-08 |
1994-07-21 |
Exemplar Corporation |
An in vitro/in vivo method for identifying anti-neoplastic drugs
|
US5610007A
(en)
*
|
1993-01-21 |
1997-03-11 |
Universite Laval |
Chimeric sheets of epithelial cells
|
GB9308271D0
(en)
*
|
1993-04-21 |
1993-06-02 |
Univ Edinburgh |
Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
|
US5650550A
(en)
*
|
1993-10-01 |
1997-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Mutant mice having a deficit of functional estrogen receptors
|
AU711183B2
(en)
*
|
1994-08-19 |
1999-10-07 |
Biotransplant Incorporated |
Genetically engineered swine cells
|
WO1996012025A1
(en)
*
|
1994-10-14 |
1996-04-25 |
Basf Aktiengesellschaft |
TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1β CONVERTING ENZYME GENE
|
EP0826034A4
(de)
*
|
1995-04-21 |
2002-06-19 |
Cell Genesys Inc |
Herstellung grosser genomischer dna-deletionen
|
US6884622B1
(en)
|
1995-04-21 |
2005-04-26 |
Abgenix, Inc |
Method for preparing a mammalian cell deficient in HPRT
|
EP0842266A4
(de)
*
|
1995-08-04 |
1999-07-21 |
Gen Hospital Corp |
Transgenes schwein und schweinezellen, die humane hla-gene aufweisen
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US7148054B2
(en)
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
GB9703550D0
(en)
*
|
1997-02-20 |
1997-04-09 |
Ppl Therapeutics Scotland Ltd |
Cell mediated transgenesis
|
US5948653A
(en)
|
1997-03-21 |
1999-09-07 |
Pati; Sushma |
Sequence alterations using homologous recombination
|
DE69842225D1
(de)
|
1997-04-16 |
2011-05-26 |
Millennium Pharm Inc |
Zusammensetzung, umfassend einen Antikörper, der selektiv an ein cysteinreiches sekretiertes Protein (CRSP) bindet
|
US6740503B1
(en)
|
1997-09-26 |
2004-05-25 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
US6897066B1
(en)
|
1997-09-26 |
2005-05-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
US6194633B1
(en)
|
1998-01-26 |
2001-02-27 |
University Of Iowa Research Foundation |
Non-human animal having a functionally disrupted SLP-76 gene
|
AU741602B2
(en)
|
1998-02-02 |
2001-12-06 |
Johns Hopkins University School Of Medicine, The |
A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
|
WO1999055838A1
(en)
*
|
1998-04-24 |
1999-11-04 |
University Of Nebraska Board Of Regents |
Compositions and methods for the characterization and transplantation of mammalian retinal stem cells
|
US6733991B1
(en)
|
1998-05-08 |
2004-05-11 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses therefor
|
US6746852B1
(en)
|
1998-05-08 |
2004-06-08 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses thereof
|
US7531715B1
(en)
|
1999-01-13 |
2009-05-12 |
Ppl Therapeutics (Scotland) |
Double nuclear transfer method and results thereof
|
WO2000046251A2
(en)
*
|
1999-02-05 |
2000-08-10 |
Buelow Jens Ulrich |
Human polyclonal antibodies from transgenic nonhuman animals
|
DE60036788T2
(de)
*
|
1999-02-18 |
2008-07-24 |
Denise L. Weston Faustman |
Verfahren zur inhibierung der abstossung von transplantaten
|
US7485293B1
(en)
|
1999-02-18 |
2009-02-03 |
Faustman Denise L |
Method for inhibiting transplant rejection
|
EP2301947A3
(de)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Sekretierte Proteine und Verwendungen dafür
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
US6808710B1
(en)
|
1999-08-23 |
2004-10-26 |
Genetics Institute, Inc. |
Downmodulating an immune response with multivalent antibodies to PD-1
|
EA013564B1
(ru)
*
|
2000-08-03 |
2010-06-30 |
Терапеутик Хьюман Поликлоналз Инк. |
Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
|
JP5113314B2
(ja)
|
2000-09-01 |
2013-01-09 |
ザ センター フォー ブラッド リサーチ インク |
所望のコンホメーションで安定させた改変ポリペプチド及び該ポリペプチドの作製方法
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
BR0115728A
(pt)
|
2000-11-28 |
2003-09-23 |
Wyeth Corp |
Análise da expressão de ácidos nucléicos kiaa e polipeptìdeos úteis no diagnóstico e tratamento de cáncer de próstata
|
NZ526708A
(en)
|
2000-11-28 |
2005-07-29 |
Wyeth Corp |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
JP3523245B1
(ja)
*
|
2000-11-30 |
2004-04-26 |
メダレックス,インコーポレーテッド |
ヒト抗体作製用トランスジェニック染色体導入齧歯動物
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
CA2430989A1
(en)
|
2000-12-06 |
2002-06-13 |
Robert J. Hariri |
Method of collecting placental stem cells
|
EP2316919B1
(de)
|
2001-02-14 |
2015-10-07 |
Anthrogenesis Corporation |
Post-partum Säugetier-Plazenta, deren Verwendung und daraus gewonnene Stammzellen
|
WO2002063962A1
(en)
|
2001-02-14 |
2002-08-22 |
Hariri Robert J |
Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
WO2002076196A1
(en)
|
2001-03-22 |
2002-10-03 |
Abbott Gmbh & Co. Kg |
Transgenic animals expressing antibodies specific for genes of interest and uses thereof
|
WO2002079499A1
(en)
|
2001-04-02 |
2002-10-10 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
CA2508763C
(en)
*
|
2001-05-11 |
2012-01-24 |
Kirin Beer Kabushiki Kaisha |
Human antibody producing mouse and method for producing human antibody using the same
|
JP2005500835A
(ja)
*
|
2001-06-29 |
2005-01-13 |
ノバルティス アクチエンゲゼルシャフト |
Pervスクリーニング法およびその使用
|
JP2005511500A
(ja)
|
2001-08-31 |
2005-04-28 |
ザ ロックフェラー ユニバーシティー |
脳におけるホスホジエステラーゼ活性およびホスホジエステラーゼ1b媒介シグナル伝達の調節
|
WO2003042362A2
(en)
|
2001-11-09 |
2003-05-22 |
Dana-Farber Cancer Institute, Inc. |
PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
|
EP2292091A1
(de)
|
2002-02-13 |
2011-03-09 |
Anthrogenesis Corporation |
Embryoartige Stammzellen aus der Post Partum Plazenta von Säugetieren sowie Anwendungszwecke und Behandlungsverfahren, bei denen diese Zellen verwendet werden
|
US7153685B2
(en)
|
2002-03-11 |
2006-12-26 |
The Board Of Trustees Of The University Of Illinois |
Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
US20040091936A1
(en)
*
|
2002-05-24 |
2004-05-13 |
Michael West |
Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
|
EP2392659B1
(de)
|
2002-06-17 |
2015-01-14 |
Thrasos Innovation, Inc. |
TDF-zugehörige Einzeldomänenverbindungen und Analoge davon
|
CA2496272A1
(en)
|
2002-08-20 |
2004-03-04 |
Millennium Pharmaceuticals, Inc. |
Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
|
KR101042448B1
(ko)
|
2002-11-26 |
2011-06-16 |
안트로제네시스 코포레이션 |
세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
|
US20050048041A1
(en)
*
|
2003-01-13 |
2005-03-03 |
Rao Mahendra S. |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EP1670350A4
(de)
|
2003-10-07 |
2008-02-13 |
Millennium Pharm Inc |
Nukleinsäuremoleküle und proteine für die identifizierung, beurteilung, prävention und behandlung von ovarialkrebs
|
WO2005046450A2
(en)
|
2003-11-12 |
2005-05-26 |
Children's Hospital Medical Center |
Method for diagnosis and treatment of pulmonary disorders
|
US7371539B2
(en)
|
2003-12-03 |
2008-05-13 |
President And Fellows Of Harvard College |
Targeted polypeptide degradation
|
CA2571218C
(en)
|
2004-06-17 |
2015-11-03 |
William D. Carlson |
Tdf-related compounds and analogs thereof
|
US7288385B2
(en)
|
2004-06-25 |
2007-10-30 |
The Salk Institute For Biological Studies |
Increasing life span by modulation of Smek
|
CA2584814A1
(en)
*
|
2004-10-22 |
2006-05-04 |
Therapeutic Human Polyclonals, Inc. |
Suppression of endogenous immunoglobulin expression in non-human transgenic animals
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
US20060148080A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Methods for supporting and producing human cells and tissues in non-human mammal hosts
|
US20060147429A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Facilitated cellular reconstitution of organs and tissues
|
EP1874811B1
(de)
|
2005-04-15 |
2012-06-13 |
President and Fellows of Harvard College |
Verfahren zur Modulation der Knochenbildung und -mineralisation durch Modulation der KRC-Aktivität
|
EP3031470A3
(de)
|
2005-09-09 |
2016-08-10 |
The Johns Hopkins University |
Manipulation der regulatorischen t-zell- und dc-funktion durch targeting des neuritin-gens mit antikörpern, agonisten und antagonisten
|
US8921109B2
(en)
|
2005-09-19 |
2014-12-30 |
Histogenics Corporation |
Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
|
CA2623415A1
(en)
|
2005-09-20 |
2007-03-29 |
Thrasos, Inc. |
Tdf-related compounds and analogs thereof
|
NZ597304A
(en)
|
2005-10-13 |
2013-06-28 |
Anthrogenesis Corp |
Immunomodulation using placental stem cells
|
JP5550235B2
(ja)
|
2005-12-29 |
2014-07-16 |
アントフロゲネシス コーポレーション |
胎盤幹細胞集団
|
CA2638774C
(en)
*
|
2006-03-31 |
2015-11-24 |
Medarex, Inc. |
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
|
US7875453B2
(en)
|
2006-06-14 |
2011-01-25 |
Bioe Llc |
Differentiation of multi-lineage progenitor cells to hepatocytes
|
US9580515B2
(en)
|
2006-08-21 |
2017-02-28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neukinase, a downstream protein of neuregulin
|
PL2064325T3
(pl)
|
2006-09-01 |
2012-05-31 |
Therapeutic Human Polyclonals Inc |
Zwiększona ekspresja ludzkiej lub humanizowanej immunoglobuliny u zwierząt transgenicznych innych niż człowiek
|
US20080188573A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Alcon Research, Ltd. |
Use of thy1-fp transgenic mouse for the identification of ophthalmic agents
|
CN103356711A
(zh)
|
2007-02-12 |
2013-10-23 |
人类起源公司 |
利用胎盘干细胞治疗炎性疾病
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
AU2008307633C1
(en)
|
2007-09-28 |
2015-04-30 |
Celularity Inc. |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
WO2009055656A2
(en)
|
2007-10-26 |
2009-04-30 |
Centocor, Inc. |
Vectors, host cells, and methods of production and uses
|
US8101354B2
(en)
*
|
2008-01-15 |
2012-01-24 |
University Of Kentucky Research Foundation |
Method for screening for a tobiano coat color genotype
|
JP6169316B2
(ja)
|
2008-08-20 |
2017-07-26 |
アンスロジェネシス コーポレーション |
改良型細胞組成物およびその作製方法
|
RU2562154C2
(ru)
|
2008-11-19 |
2015-09-10 |
Антродженезис Корпорейшн |
Амниотические адгезивные клетки
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
EP2261242A1
(de)
|
2009-06-10 |
2010-12-15 |
Universite Catholique De Louvain |
Aspartat-N-Acetyltransferaseenzym, Diagnoseverfahren und therapeutisches Verfahren
|
CA3049393C
(en)
|
2009-09-23 |
2020-12-29 |
Restem Llc |
Umbilical cord lining stem cells and methods and material for isolating and culturing same
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
US10429384B2
(en)
|
2010-01-22 |
2019-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
ES2646750T3
(es)
|
2010-01-26 |
2017-12-15 |
Anthrogenesis Corporation |
Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
KR20190076060A
(ko)
|
2010-04-07 |
2019-07-01 |
안트로제네시스 코포레이션 |
태반 줄기 세포를 사용한 혈관신생
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
WO2012009422A1
(en)
|
2010-07-13 |
2012-01-19 |
Anthrogenesis Corporation |
Methods of generating natural killer cells
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
US9956236B2
(en)
|
2011-02-07 |
2018-05-01 |
Cornell University |
Methods for increasing immune responses using agents that directly bind to and activate IRE-1
|
WO2012122512A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Recombinant production of mixtures of single chain antibodies
|
ES2707579T3
(es)
|
2011-06-01 |
2019-04-04 |
Celularity Inc |
Tratamiento del dolor usando citoblastos placentarios
|
WO2013039996A1
(en)
|
2011-09-13 |
2013-03-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using fndc5
|
WO2013053076A1
(en)
|
2011-10-10 |
2013-04-18 |
Zensun (Shanghai)Science & Technology Limited |
Compositions and methods for treating heart failure
|
US9043996B2
(en)
|
2011-10-28 |
2015-06-02 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex animals
|
US9591835B2
(en)
|
2011-10-28 |
2017-03-14 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex animals
|
LT3590332T
(lt)
|
2011-10-28 |
2022-08-10 |
Regeneron Pharmaceuticals, Inc. |
Genetiškai modifikuotos pelės, ekspresuojančios chimerines pagrindinio audinių dermės komplekso (mhc) ii molekules
|
CN107254480B
(zh)
|
2011-10-28 |
2021-08-10 |
瑞泽恩制药公司 |
制备主要组织相容性复合物基因修饰小鼠的方法
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
PT2814844T
(pt)
|
2012-02-15 |
2017-09-18 |
Novo Nordisk As |
Anticorpos que se ligam e bloqueiam recetor de acionamento expresso em células mieloides-1 (trem-1)
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
AU2014215458A1
(en)
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
SI2958938T1
(sl)
|
2013-02-20 |
2019-08-30 |
Regeneron Pharmaceuticals, Inc. |
Miši, ki izražajo humanizirane koreceptorje za celice T
|
CN105164154B
(zh)
|
2013-02-22 |
2019-06-07 |
瑞泽恩制药公司 |
表达人源化主要组织相容性复合物的小鼠
|
US20150342163A1
(en)
|
2013-02-22 |
2015-12-03 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex mice
|
DK3049521T3
(en)
|
2013-09-25 |
2019-04-23 |
Univ Cornell |
Compounds for inducing antitumor immunity and methods thereof
|
US10077420B2
(en)
|
2014-12-02 |
2018-09-18 |
Histogenics Corporation |
Cell and tissue culture container
|
BR112017021250A2
(pt)
|
2015-04-06 |
2018-06-26 |
Regeneron Pharma |
respostas imunes mediadas por células t humanizadas em animais não humanos
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|